Bowel cancer screening in older patients: is it time to reconsider?

Frommer, Donald J

doi:10.5694/mja2.50915

Topics

Digestive system diseases

Environment and public health

Gerontology

Neoplasms

To the Editor: In 1996, two articles showed that bowel cancer screening in subjects aged 45–741 and 45–752 years, recruited in the early 1980s, led to a significant reduction in mortality; since then, the age range in Australia’s screening program remains at 50–74 years.

1 University of New South Wales, Sydney, NSW
2 University of Sydney, Sydney, NSW

Correspondence: donfrommer@yahoo.co.uk

Competing interests:

No relevant disclosures.

1. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal‐occult‐blood screening for colorectal cancer. Lancet 1996; 30(348): 1472–1427.
2. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal‐occult‐blood test. Lancet 1996; 30(348): 1467–1471.
3. Australian Bureau of Statistics. Australian historical population statistics. 2016 [Cat. No. 3105.0.65.001]. https://www.abs.gov.au/AUSSTATS/abs@.nsf/mf/3105.0.65.001 (viewed Dec 2020).
4. Australia Institute of Health and Welfare. Cancer data in Australia [Cat. No. CAN 122]. https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia/data (viewed Dec 2020).
5. American Cancer Society. Colorectal cancer facts and figures 2017–2019. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/colorectal-cancer-facts-and-figures/colorectal-cancer-facts-and-figures-2017-2019.pdf (viewed Dec 2020).
6. Australia Institute of Health and Welfare. National cancer screening programs participation data [Cat. No. CAN 114]; updated 2 Dec 2019. https://www.aihw.gov.au/reports/cancer-screening/national-cancer-screening-programs-participation/contents/national-bowel-cancer-screening-program/participation (viewed Dec 2020).
7. García‐Albéniz X, Hsu J, Bretthauer M, Hernán MA. Effectiveness of screening colonoscopy to prevent colorectal cancer among medicare beneficiaries aged 70 to 79 years: a prospective observational study. Ann Intern Med 2017; 166: 18–26.
8. van Hees F, Habbema JD, Meester RG, et al. Should colorectal cancer screening be considered in elderly persons without previous screening? A cost‐effectiveness analysis. Ann Intern Med 2014; 160(11): 750–759.
9. Lew Jie‐Bin, St John D, James B, et al. Benefits, harms, and cost‐effectiveness of potential age extensions to the National Bowel Cancer Screening Program in Australia. Cancer Epidemiol Biomarkers Prev 2018; 27(12): 1450–1461. https://doi.org/10.1158/1055-9965.epi-18-0128.

Online responses are no longer available. Please refer to our instructions for authors page for more information.